Chinese Medical E-ournals Database
Adv Search
中华妇幼临床医学杂志(电子版)

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2022, Vol. 18 ›› Issue (05): 517 -522. doi: 10.3877/cma.j.issn.1673-5250.2022.05.004

Forum

Research progress on probiotics in clinical application of neonatal respiratory diseases

Jinli Yan, Dapeng Chen†()   

  1. Department of Neonatology, Key Laboratory of Birth Defects and Related Disseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2022-03-27 Revised:2022-08-31 Published:2022-10-01
  • Corresponding author: Dapeng Chen
  • Supported by:
    National Key Research and Development Program(2017YFC0109004)
HTML ( ) PDF ( )

Neonatal respiratory system disease is a common disease of newborns and a common cause of neonatal death. Probiotics are a kind of active microorganisms beneficial to the host by colonizing the human body and changing the composition of a certain part of the host. In recent years, researches on the relationship between probiotics and neonatal respiratory diseases have become a hot topic in this field. Probiotics can enhance the intestinal immune function and improve the systemic immunity of newborns, so as to suppress the pathological and pathophysiological functions of respiratory diseases and achieve purpose of treating these diseases. The author reviews the research progress on the definition and types of probiotics, safety, adverse effects and therapeutic mechanism of clinical application of probiotics in neonates, and probiotics in treatment of neonatal respiratory diseases, so as to enable pediatricians to better understand the role of probiotics in treatment ofsuch diseases.

Key words: Probiotics, Enteropulmonary axis, Pneumonia, ventilator-associated, Bronchopulmonary dysplasia, Meconium aspiration syndrome, Asthma, Infant, newborn
[1]
Harper A, Vijayakumar V, Ouwehand AC, et al. Viral infections, the microbiome, and probiotics[j]. Front Cell Infect Microbiol, 2021, 10: 596166. DOI: 10.3389/fcimb.2020.596166.
[2]
Sharifi-Rad J, Rodrigues CF, Stojanović-Radić Z, et al. Probiotics: versatile bioactive components in promoting human health[J]. Medicina, 2020, 56(9): 433. DOI: 10.3390/medicina56090433.
[3]
Zhou A, Lei Y, Tang L, et al. Gut microbiota: the emerging link to lung homeostasis and disease[J]. J Bacteriol, 2021, 203(4): e00454-20. DOI: 10.1128/JB.00454-20.
[4]
Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis[J]. Mucosal Immunol, 2019, 12(4): 843-850. DOI: 10.1038/s41385-019-0160-6.
[5]
Hill C, Guarner F, Reid G, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(8): 506-514. DOI: 10.1038/nrgastro.2014.66.
[6]
中华预防医学会微生态学分会． 中国微生态调节剂临床应用专家共识(2020版)[J]. 中国微生态学杂志，2020, 32(8): 953-965. DOI: 10.13381/j.cnki.cjm.202008020.
[7]
王华． 早产儿益生菌使用的国内现状及文献系统回顾[J]. 中华实用儿科临床杂志，2021, 36(14): 1063-1067. DOI: 10.3760/cma.j.cn101070-20201122-01790.
[8]
Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, et al. Mechanisms of action of probiotics[J]. Adv Nutr, 2019, 10(suppl_1): S49-S66. DOI: 10.1093/advances/nmy063.
[9]
Van den Akker CHP, Van Goudoever JB, Shamir R, et al. Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics[J]. J Pediatr Gastroenterol Nutr, 2020, 70(5): 664-680. DOI: 10.1097/MPG.0000000000002655.
[10]
Poindexter B, Cummings J, Hand I, et al. Use of probiotics in preterm infants[J]. Pediatrics, 2021, 147(6): e2021051485. DOI: 10.1542/peds.2021-051485.
[11]
Rangelova VR, Raycheva RD, Kevorkyan AK, et al. Ventilator-associated pneumonia in neonates admitted to a tertiary care NICU in Bulgaria[J]. Front Pediatr, 2022, 10: 909217. DOI: 10.3389/fped.2022.909217.
[12]
张应金，苏永棉，梁凤潇，等. 益生菌预防新生儿呼吸机相关性肺炎的临床疗效研究[J]. 中国小儿急救医学，2012, 19(14): 405-407. DOI: 10.3760/cma.j.issn.1673-4912.2012.04.022.
[13]
吴香兰，李月凤，周北燕，等. 双歧杆菌对机械通气新生儿呼吸道和胃肠道的影响[J]. 中国当代儿科杂志，2011, 13(9): 704-707. DOI: 10.1007/s12583-011-0153-1.
[14]
李学超，王建忠，刘元辉. 益生菌对机械通气新生儿呼吸道致病菌定植的影响[J]. 中国当代儿科杂志，2012, 14(6): 406-408. DOI: 10.1007/s11783-011-0280-z.
[15]
刘雅文．益生菌制剂预防呼吸机相关性肺炎的Meta分析[D]. 南昌：南昌大学，2018.
[16]
解军． 双歧杆菌对新生儿呼吸机相关性肺炎的预防效果[J]. 中国社区医师，2018, 34(4): 36-37. DOI: 10.3969/j.issn.1007-614x.2018.4.21.
[17]
Permall DL, Pasha AB, Chen X, et al. The lung microbiome in neonates[J]. Turk J Pediatr, 2019, 61(6): 821-830. DOI: 10.24953/turkjped.2019.06.001.
[18]
Li Y, He L, Zhao Q, et al. Microbial and metabolic profiles of bronchopulmonary dysplasia and therapeutic effects of potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidum[J]. J Appl Microbiol, 2022, 133(2): 908-921. DOI: 10.1111/jam.15602.
[19]
Qu Y, Guo S, Liu Y, et al. Association between probiotics and bronchopulmonary dysplasia in preterm infants[J]. Sci Rep, 2021, 11(1): 1-6. DOI: 10.1038/s41598-021-96489-z.
[20]
范佳英．早产儿肠道菌群变化与支气管肺发育不良症的相关研究[D]. 苏州：苏州大学，2020.
[21]
Chen SM, Lin CP, Jan MS. Early gut microbiota changes in preterm infants with bronchopulmonary dysplasia: a pilot case-control study[J]. Am J Perinatol, 2021, 38(11): 1142-1149. DOI: 10.1055/s-0040-1710554.
[22]
Yang K, Dong W. Perspectives on probiotics and bronchopulmonary dysplasia[J]. Front Pediatr, 2020, 8: 570247. DOI: 10.3389/fped.2020.570247.
[23]
魏贤，杨树杰，甘斌，等. 补充益生菌对胎粪吸入综合征患儿免疫功能的影响[J]. 中华全科医学，2016, 14(12): 2057-2059. DOI: 10.16766/j.cnki.issn.1674-4152.2016.12.027.
[24]
Krusche J, Basse S, Schaub B. Role of early life immune regulation in asthma development[J]. Semin Immunopathol, 2020, 42(1): 29-42. DOI: 10.1007/s00281-019-00774-z.
[25]
Wu Z, Mehrabi Nasab E, Arora P, et al. Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway[J]. J Transl Med, 2022, 20(1): 1-14. DOI: 10.1186/s12967-022-03337-3.
[26]
Altman MC, Beigelman A, Ciaccio C, et al. Evolving concepts in how viruses impact asthma: a Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology[J]. J Allergy Clin Immunol, 2020, 145(5): 1332-1344. DOI: 10.1016/j.jaci.2019.12.904.
[27]
肖小兵，邓建荣，聂煜哲，等. 5岁以下儿童支气管哮喘发病与其母亲孕期及新生儿时期的相关因素分析[J]. 临床肺科杂志，2019, 24(4): 705-708. DOI: 10.3969/j.issn.1009-6663.2019.04.030.
[28]
曾双志，秦微，谭稻香，等. 肠道菌群制剂对新生儿哮喘57例防治效果观察[J]. 现代诊断与治疗，2015, 26(13): 2956-2957.
[29]
Sestito S, D′Auria E, Baldassarre ME, et al. The role of prebiotics and probiotics in prevention of allergic diseases in infants[J]. Front Pediatr, 2020, 8: 583946. DOI: 10.3389/fped.2020.583946.
[30]
Manna S, Chowdhury T, Chakraborty R, et al. Probiotics-derived peptides and their immunomodulatory molecules can play a preventive role against viral diseases including COVID-19[J]. Probiotics Antimicrob Proteins, 2021, 13(3): 611-623. DOI: 10.1007/s12602-020-09727-7.
[31]
Monteiro CRAV, do Carmo MS, Melo BO, et al. In vitro antimicrobial activity and probiotic potential of Bifidobacterium and Lactobacillus against species of clostridium[J]. Nutrients, 2019, 11(2): 448. DOI: 10.3390/nu11020448.
[32]
Du T, Lei A, Zhang N, et al. The beneficial role of probiotic Lactobacillus in respiratory diseases[J]. Front Immunol, 2022, 13: 908010. DOI: 10.3389/fimmu.2022.908010.
[33]
Chen J, Chen X, Ho CL. Recent development of probiotic Bifidobacteria for treating human diseases[J]. Front Bioeng Biotechnol, 2021, 9: 770248. DOI: 10.3389/fbioe.2021.770248.
[1] Haoyuan Yang, Jie Gong, Qingwei Zou, Hang Ruan. Current research status on adverse pregnancy outcomes of maternal and infant in pregnant women with asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 522-529.
[2] Zhengyun Hu, Jianwei Shi, Jianwei Shen, Bing Wang, Chunmiao Jiang, Chong Liu. Identification of hub genes associated with bronchopulmonary dysplasia in preterm infants based on machine learning[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 446-454.
[3] Lili Lou, Hanmin Liu. Current research status of susceptibility genes and epigenetics on childhood asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 249-255.
[4] Ping Yang, Shimin Xu, Liangliang Li, Xiangyun Yin, Hongmin Xi, Lili Ma, Xianghong Li. Influencing factors of bronchopulmonary dysplasia complicated with metabolic bone disease in preterm infants[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(02): 202-211.
[5] Bing Yuan, Kai Yan. Current research status in treatment of preterm infants with bronchopulmonary dysplasia by human amniotic epithelial stem cells[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(06): 640-644.
[6] Hongling Fu, Hanmin Liu. Research progress on signaling pathways involved in bronchopulmonary dysplasia and pulmonary hypertension[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(05): 497-505.
[7] Yan Liu, Ming Zhao, Hong Jiang, Chen Chen, Xiaoqin Wang, Lei Zhang. Risk factors of bronchopulmonary dysplasia in very preterm infants: a multicenter study[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(04): 419-426.
[8] Lingfang Tan, Kebing Zhou. Identification of biomarkers associated with diagnosis of bronchial asthma based on integrated bioinformatics analysis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(03): 329-334.
[9] Jixin He, Yanni Yang, Jiwei Wang, Jianguo Li, Ming Xie. Research progress on the mechanism of intestinal flora metabolites involved in the occurrence of chronic constipation[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 495-499.
[10] Na Li, Guozhen Zhu. Progress of research on the roles of gut microbiota and its metabolites in acute kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(04): 215-219.
[11] Jingen Xia, Shiyu Hu. Application scenario of extracorporeal carbon dioxide removal technology in Intensive Care Unit[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 40-45.
[12] Yingzhi Wang, Xianjin Zhang, Shiyan Yang. Effects of probiotics combined with early enteral nutrition on nutritional status, intestinal mucosal barrier function and enteral nutrition tolerance in patients with severe acute pancreatitis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(01): 55-58.
[13] Mingjing Lin, Dong Cai, Wenting Feng, Fangfang Wu, Kaiyan Zhang. Risk factors for bronchopulmonary dysplasia in premature infants born from 2017 to 2019[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(09): 908-913.
[14] Yiping Zhu, Yiping Chen, Yanying Zhao, Weiwei Lu, Houjun Ya, Fuxia Su. Mechanism for Ershiwei Chenxiang pills to regulate composition of probiotics in intestinal flora of diabetic nephropathy rats[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(06): 572-578.
[15] Yu Liu, Ning Wang, Dan Li, Bo Zhang. Probiotics for adjuvant treatment of diarrhea associated with bronchopneumonia in children: efficacy and impact on intestinal flora[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(05): 410-414.
Viewed
Full text


Abstract

Copyright © Chinese Medical Association, Chinese Medical Multimedia Press  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号